ZyVersa Therapeutics Stock (NASDAQ:ZVSA), Quotes and News Summary

Q: What sector and industry does ZyVersa Therapeutics (ZVSA) operate in?

ZyVersa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ZyVersa Therapeutics Stock (NASDAQ: ZVSA) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 290.358K
Day Range	- - -
52 Wk Range	4.440 - 360.500
Market Cap	$4.018M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	30
Short Interest	60.83%
Days to Cover	1.42

Recent News

Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Avi Kapoor

What's Going On With ZyVersa Stock?

ZyVersa Therapeutics shares are trading higher Monday after the company announced the publication of a scientific paper in a peer-reviewed journal that reinforces the rationale for inhibiting ASC with IC 100 to potentially attenuate cardiac comorbidities in patients with Alzheimer's Disease.

Erica Kollmann

Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy ZyVersa Therapeutics (ZVSA) stock?

You can purchase shares of ZyVersa Therapeutics (NASDAQ: ZVSA) through any online brokerage.

View our list of the best stock brokerages.

Who are ZyVersa Therapeutics's (ZVSA) competitors?

Other companies in ZyVersa Therapeutics’s space includes: Alzamend Neuro (NASDAQ:ALZN), Tharimmune (NASDAQ:THAR), Quoin Pharmaceuticals (NASDAQ:QNRX), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and Geovax Labs (NASDAQ:GOVX).

What is the target price for ZyVersa Therapeutics (ZVSA) stock?

The latest price target for ZyVersa Therapeutics (NASDAQ: ZVSA) was reported by HC Wainwright & Co. on Tuesday, March 26, 2024. The analyst firm set a price target for 12.00 expecting ZVSA to rise to within 12 months (a possible 126.84% upside). 4 analyst firms have reported ratings in the last year.

Current Stock Price for ZyVersa Therapeutics (ZVSA)?

The stock price for ZyVersa Therapeutics (NASDAQ: ZVSA) is $5.29 last updated May 14, 2024 at 6:58 PM EDT.

Does ZyVersa Therapeutics (ZVSA) pay a dividend?

There are no upcoming dividends for ZyVersa Therapeutics.

When is ZyVersa Therapeutics (NASDAQ:ZVSA) reporting earnings?

ZyVersa Therapeutics’s Q4 earnings are confirmed for Tuesday, May 28, 2024.

Is ZyVersa Therapeutics (ZVSA) going to split?

There is no upcoming split for ZyVersa Therapeutics.

What sector and industry does ZyVersa Therapeutics (ZVSA) operate in?

ZyVersa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-